Common Contracts

957 similar Underwriting Agreement contracts by StandardAero, Inc., Flowco Holdings Inc., Moove Lubricants Holdings, others

Eos Energy Enterprises, Inc. 18,750,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • June 2nd, 2025 • Eos Energy Enterprises, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York

Substantially concurrently with the offer and sale to the Underwriters of the Underwritten Shares, the Company. will offer and sell (the “Concurrent Offering”) to certain initial purchasers $225,000,000 (or up to $250,000,000 if the initial purchasers’ option is exercised) aggregate principal amount of its 6.75% Convertible Senior Notes due 2030 (the “Notes”) pursuant to the terms of a separate purchase agreement dated as of the date hereof (the “Notes Purchase Agreement”).

Sandisk Corporation Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 30th, 2025 • Sandisk Corp • Computer storage devices • New York

Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sandisk Corporation, a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of Common Stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Sable Offshore Corp. 8,695,654 Shares of Common Stock, Par Value $0.0001 Per Share Underwriting Agreement
Underwriting Agreement • May 23rd, 2025 • Sable Offshore Corp. • Crude petroleum & natural gas • New York
Centuri Holdings, Inc. 9,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 22nd, 2025 • Southwest Gas Holdings, Inc. • Natural gas transmisison & distribution • New York

Southwest Gas Holdings, Inc., a stockholder (the “Selling Stockholder”) of Centuri Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 9,000,000 shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Selling Stockholder proposes to sell, at the option of the Underwriters, up to an additional 1,350,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

FORM OF UNDERWRITING AGREEMENT STANDARDAERO, INC. [•] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 19th, 2025 • StandardAero, Inc. • Aircraft engines & engine parts • New York

The stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of StandardAero, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock (the “Common Stock”), par value $0.01 per share, of the Company (collectively, the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

SANGAMO THERAPEUTICS, INC. 12,235,000 Shares of Common Stock par value $0.01 per share Pre-Funded Warrants to Purchase up to 34,398,393 Shares of Common Stock Warrants to Purchase up to 46,633,393 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 13th, 2025 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • New York

Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of (i) 12,235,000 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Shares”), (ii) pre-funded warrants to purchase up to an aggregate of 34,398,393 shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrants”) and (iii) warrants to purchase up to an aggregate of 46,633,393 shares of Common Stock (the “Warrants” and, together with the Shares and the Pre-Funded Warrants, the “Underwritten Securities”). The Common Stock issuable upon the exercise of the Pre-Funded Warrants is referred to herein as the “Pre-Funded Warrant Shares.” The Common Stock issuable upon the exercise of the Warrants is referred to herein as the “Warrant Shares.” The Underwritten Securities, the Pre

UNDERWRITING AGREEMENT American Integrity Insurance Group, Inc. [ ] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • April 29th, 2025 • American Integrity Insurance Group, Inc. • Fire, marine & casualty insurance • New York

American Integrity Insurance Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] shares of common stock, par value $0.001 per share (“Common Stock”), of the Company and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of [ ] shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional [ ] shares of Common Stock (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The Shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Sto

UNDERWRITING AGREEMENT SPORTRADAR GROUP AG 23,000,000 Shares of Class A Ordinary Shares Underwriting Agreement
Underwriting Agreement • April 25th, 2025 • Sportradar Group AG • Services-computer programming, data processing, etc. • New York

Certain shareholders named in Schedule 2 hereto (the “Selling Shareholders”) of Sportradar Group AG, a Swiss corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate of 23,000,000 shares of Class A ordinary shares, each having a nominal value of CHF 0.10, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,450,000 shares of Class A ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The Class A ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.” Subject to the sale of the Shares by the Selling Shareholders to the Underwriters in compliance with the terms of this Agreement, the Underwriters have agreed to sell to the Compan

FORM OF UNDERWRITING AGREEMENT Circle Internet Group, Inc. [•] Shares of Class A Common Stock
Underwriting Agreement • April 18th, 2025 • Circle Internet Group, Inc. • Finance services • New York

Circle Internet Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of [•] shares of Class A Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [•] shares of Class A Common Stock of the Company, and the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional [•] shares of Class A Common Stock (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are h

Ategrity Specialty Insurance Company Holdings [●] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • April 15th, 2025 • Ategrity Specialty Holdings LLC • Fire, marine & casualty insurance • New York

Ategrity Specialty Insurance Company Holdings, a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

UNDERWRITING AGREEMENT Edgewise Therapeutics, Inc. 9,935,419 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • April 2nd, 2025 • Edgewise Therapeutics, Inc. • Pharmaceutical preparations • New York

Edgewise Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 9,935,419 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

STANDARDAERO, INC. [•] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • March 24th, 2025 • StandardAero, Inc. • Aircraft engines & engine parts • New York

The stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of StandardAero, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock (the “Common Stock”), par value $0.01 per share, of the Company (collectively, the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

InflaRx N.V. 8,250,000 Ordinary Shares and Pre-Funded Warrants to Purchase 6,750,000 Ordinary Shares Underwriting Agreement
Underwriting Agreement • February 18th, 2025 • InflaRx N.V. • Pharmaceutical preparations • New York

InflaRx N.V., a public limited liability company (naamloze vennootschap) under Dutch law, (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), (i) an aggregate of 8,250,000 ordinary shares, nominal value €0.12 per share (the “Ordinary Shares”), of the Company (the “Underwritten Shares”) and pre-funded warrants to purchase an aggregate of 6,750,000 Ordinary Shares of the Company, at an exercise price equal to $0.001 per share, in a form to be mutually agreed upon by the Company and the Underwriters (the “Warrants”) and (ii) at the option of the Underwriters, up to an additional 2,250,000 Ordinary Shares of the Company (the “Option Shares”). The Underwritten Shares, the Warrants and the Option Shares are referred to herein as the “Securities”. The Ordinary Shares of the Company issuable upon exercise of the Warrants are herein referred to as the “Warrant

NeuroPace, Inc. 6,500,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • February 18th, 2025 • NeuroPace Inc • Surgical & medical instruments & apparatus • New York

NeuroPace, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 6,500,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 975,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Immunome, Inc. 19,354,839 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • January 30th, 2025 • Immunome Inc. • Pharmaceutical preparations • New York
HMH Holding Inc. [ ] Shares of Class A Common Stock Form of Underwriting Agreement
Underwriting Agreement • January 27th, 2025 • HMH Holding Inc • Oil & gas field machinery & equipment • Delaware

HMH Holding Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] shares of Class A common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the

MAZE THERAPEUTICS, INC. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • January 27th, 2025 • Maze Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Flowco Holdings Inc. 17,800,000 Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • January 21st, 2025 • Flowco Holdings Inc. • Oil & gas field machinery & equipment • New York

Flowco Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 17,800,000 shares of Class A common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 2,670,000 shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Ascentage Pharma Group International [·] American Depositary Shares Representing [·] Ordinary Shares (par value US$0.0001 per share) Underwriting Agreement
Underwriting Agreement • January 21st, 2025 • Ascentage Pharma Group International • Pharmaceutical preparations • New York

Ascentage Pharma Group Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [·] American Depositary Shares (“ADSs”), each ADS representing [·] ordinary shares (the “Ordinary Shares”), par value US$0.0001 per share, of the Company (the “Underwritten Securities”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [·] ADSs (the “Option Securities”). The Underwritten Securities and the Option Securities are herein referred to as the “Offered Securities.” The ADSs are to be issued pursuant to a Deposit Agreement dated as of [·], 2025 (the “Deposit Agreement,” and together with this Agreement, the “Transaction Documents”) among the Company, JPMorgan Chase Bank, N.A., as Depositary (the “Depositary”), and th

Flowco Holdings Inc. [ ⚫ ] Shares of Class A Common Stock Form of Underwriting Agreement
Underwriting Agreement • January 7th, 2025 • Flowco Holdings Inc. • Oil & gas field machinery & equipment • New York

Flowco Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ⚫ ] shares of Class A common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [ ⚫ ] shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Venture Global, Inc. [●] Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • December 20th, 2024 • Venture Global, Inc. • Natural gas distribution • New York

Venture Global, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of Class A Common Stock, par value $0.01 per share (“Class A Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Class A Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

23,000,000 Underwritten Shares of Class A Common Stock Underwriting Agreement December 16, 2024
Underwriting Agreement • December 18th, 2024 • EVgo Inc. • Services-automotive repair, services & parking • New York

The stockholder named in Schedule 2 hereto (the “Selling Stockholder”) of EVgo Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 23,000,000 shares of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock” and such shares, the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,450,000 shares of Class A Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

CHEWY, INC. 15,852,886 Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • December 13th, 2024 • Chewy, Inc. • Retail-catalog & mail-order houses • New York

Buddy Chester Sub LLC, a Delaware limited liability company (the “Selling Stockholder”), a stockholder of Chewy, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 15,852,886 shares of Class A common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”).

Replimune Group, Inc. 6,923,000 Shares of Common Stock Pre-Funded Warrants to Purchase 3,846,184 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • November 27th, 2024 • Replimune Group, Inc. • Biological products, (no disgnostic substances) • New York

Replimune Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Leerink Partners LLC (the “Underwriter”) an aggregate of 6,923,000 shares (the “Underwritten Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”), pre-funded warrants to purchase an aggregate of 3,846,184 shares of Common Stock in a form to be mutually agreed by the Company and the Underwriter (the “Warrants”) and, at the option of the Underwriter, up to an additional 1,615,377 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Warrants are herein referred to as the “Underwritten Securities”. The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock issuable upon exercise of the Warrants are herein referred to as the “Warrant Shares”. The Shares and Warrants are herein referred to as the “Securities”. The shares of Common Stock to be outstanding after giving effect to the sale

GRID DYNAMICS HOLDINGS, INC. Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • November 14th, 2024 • Grid Dynamics Holdings, Inc. • Services-prepackaged software • New York

Grid Dynamics Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,750,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 862,500 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

VERA THERAPEUTICS, INC. 7,142,858 Shares of Class A Common Stock Underwriting Agreement
Underwriting Agreement • October 31st, 2024 • Vera Therapeutics, Inc. • Pharmaceutical preparations • New York

Vera Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“J.P. Morgan”), Goldman Sachs & Co. LLC (“Goldman Sachs”), Evercore Group L.L.C. (“Evercore”) and Cantor Fitzgerald & Co. (“Cantor”) are acting as representatives (the “Representatives”), an aggregate of 7,142,858 shares (the “Underwritten Shares”) of Class A common stock, par value $0.001 per share, of the Company and, at the option of the Underwriters, up to an additional 1,071,428 shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Septerna, Inc. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 21st, 2024 • Septerna, Inc. • Pharmaceutical preparations • New York
CRINETICS PHARMACEUTICALS, INC. 10,000,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 9th, 2024 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to 1,500,000 additional shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Upstream Bio, Inc. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • October 7th, 2024 • Upstream Bio, Inc. • Pharmaceutical preparations • New York
MOOVE LUBRICANTS HOLDINGS [25,000,000] Common Shares, par value US$0.000333333333333 per share Underwriting Agreement
Underwriting Agreement • October 1st, 2024 • Moove Lubricants Holdings • Miscellaneous products of petroleum & coal • New York

Moove Lubricants Holdings, a Cayman Islands exempted company with limited liability (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [6,250,000] common shares, par value US$0.000333333333333 per share, of the Company, the shareholder of the Company named in Section 1 of Schedule 2 hereto (“Cosan”) and the shareholder of the Company named in Section 2 of Schedule 2 hereto (the “CVC Fund VII” and, together with Cosan, the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [18,750,000] common shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [3,750,000] common shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein refer

MOOVE LUBRICANTS HOLDINGS [25,000,000] Common Shares, par value US$0.000333333333333 per share Underwriting Agreement
Underwriting Agreement • October 1st, 2024 • Moove Lubricants Holdings • Miscellaneous products of petroleum & coal • New York

Moove Lubricants Holdings, a Cayman Islands exempted company with limited liability (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [6,250,000] common shares, par value US$0.000333333333333 per share, of the Company, the shareholder of the Company named in Section 1 of Schedule 2 hereto (“Cosan”) and the shareholder of the Company named in Section 2 of Schedule 2 hereto (the “CVC Fund VII” and, together with Cosan, the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [18,750,000] common shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [3,750,000] common shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein refer

STANDARDAERO, INC. 60,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 27th, 2024 • StandardAero, Inc. • Aircraft engines & engine parts • New York

StandardAero, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 53,250,000 shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”), and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of 6,750,000 shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional 9,000,000 shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “St

camp4 therapeutics corporation [•] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • September 26th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • New York

CAMP4 Therapeutics Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

INVENTRUST PROPERTIES CORP. 8,000,000 Shares of common stock, $0.001 par value per share Underwriting Agreement
Underwriting Agreement • September 25th, 2024 • InvenTrust Properties Corp. • Real estate investment trusts • New York

InvenTrust Properties Corp., a Maryland corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,200,000 shares of common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

BLACKSKY TECHNOLOGY INC. 10,000,000 Shares of Class A Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • September 25th, 2024 • BlackSky Technology Inc. • Radio & tv broadcasting & communications equipment • New York

BlackSky Technology Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 10,000,000 shares (the “Underwritten Shares”) of Class A common stock, par value $0.0001 per share (“Common Stock”), of the Company and, at the option of the Underwriters, up to an additional 1,500,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”